Jyothy Labs Ltd. (JYOTHYLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 973634,
    "name": "Jyothy Labs",
    "stock_name": "Jyothy Labs",
    "full_name": "Jyothy Labs Ltd.",
    "name_url": "stocks-analysis/jyothy-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "244.00",
    "chg": 3.4,
    "chgp": "1.41%",
    "dir": 1,
    "prev_price": "240.60",
    "mcapval": "8,977.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532926,
    "symbol": "JYOTHYLAB",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE668F01031",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "2.78 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/jyothy-labs-973634-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Jyothy Labs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-jyothy-labs-fallingrising-3745021",
        "imagepath": "",
        "date": "2025-12-04 00:54:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Jyothy Labs closed at ₹291.95, down ₹3.55 or 1.2% as of 08:57 PM on 03-Dec. The stock has been on a consistent decline, losing 5.33% over the past week and underperforming its sector by 0.32% on the day. This marks the fifth consecutive day of losses, with the stock falling 5.33% during this period. Notably, Jyothy Labs is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.</p>\n<p>Investor participation has seen a slight uptick, with delivery volumes rising by 2.09% to 2.33 lakh shares on 02 Dec compared to the five-day average. The stock remains sufficiently liquid, supporting trade sizes of approximately ₹0.22 crore based on 2% of the fi..."
      },
      {
        "title": "Jyothy Labs Sees Revision in Market Evaluation Amidst Challenging FMCG Landscape",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jyothy-labs-downgraded-to-sell-by-marketsmojo-amidst-weak-financial-and-technical-signals-3733007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JyothyLabs_mojoScore_3733007.png",
        "date": "2025-11-27 10:06:45",
        "description": "Jyothy Labs has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor perception. The recent changes highlight a complex interplay of factors including quality, valuation, financial trends, and technical outlook within the FMCG sector."
      },
      {
        "title": "How has been the historical performance of Jyothy Labs?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jyothy-labs-3695508",
        "imagepath": "",
        "date": "2025-11-13 00:27:57",
        "description": "Answer:\nThe historical performance of Jyothy Labs shows a consistent growth trajectory in net sales and profitability over the years.\n\nBreakdown:\nJyothy Labs has demonstrated a steady increase in net sales from INR 1,711.17 crore in March 2020 to INR 2,846.98 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached INR 2,846.98 crore in March 2025, up from INR 1,711.17 crore in March 2020. The company's operating profit (PBDIT) also reflects this positive trend, increasing from INR 271.08 crore in March 2020 to INR 555.17 crore in March 2025. Profit before tax has similarly improved, rising from INR 181.50 crore in March 2020 to INR 488.81 crore in March 2025. The profit after tax has shown a notable increase as well, from INR 162.58 crore in March 2020 to INR 370.38 crore in March 2025. In terms of assets, total assets grew from INR 1,733.49 crore in March 2020 to ..."
      },
      {
        "title": "Is Jyothy Labs overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jyothy-labs-overvalued-or-undervalued-3684187",
        "imagepath": "",
        "date": "2025-11-10 08:12:33",
        "description": "As of 7 November 2025, the valuation grade for Jyothy Labs has moved from very attractive to attractive, indicating a shift in perception regarding its market valuation. The company is currently assessed as fairly valued. Key ratios include a PE ratio of 30.63, an EV to EBITDA of 21.82, and a ROCE of 29.33%. \n\nWhen compared to its peers, Jyothy Labs' PE ratio is significantly lower than that of Hindustan Unilever at 53.63 and Nestle India at 81.21, both categorized as very expensive. Despite the attractive valuation, Jyothy Labs has underperformed in the market, with a year-to-date return of -21.62% compared to a 6.50% gain in the Sensex. This performance reinforces the notion that while the company is fairly valued, it may face challenges in the near term...."
      },
      {
        "title": "Is Jyothy Labs overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jyothy-labs-overvalued-or-undervalued-3682864",
        "imagepath": "",
        "date": "2025-11-09 08:10:52",
        "description": "As of 7 November 2025, the valuation grade for Jyothy Labs has moved from very attractive to attractive. The company is currently considered fairly valued. Key ratios include a PE ratio of 30.63, an EV to EBITDA ratio of 21.82, and a ROCE of 29.33%. \n\nIn comparison to its peers, Jyothy Labs has a significantly lower valuation than Hindustan Unilever, which has a PE ratio of 53.63, and Nestle India, with a PE ratio of 81.21. Despite its recent stock performance underperforming the Sensex, with a YTD return of -21.62% compared to the Sensex's 6.50%, the company's solid ROCE and attractive valuation relative to its peers suggest it remains a viable investment option...."
      },
      {
        "title": "Is Jyothy Labs overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jyothy-labs-overvalued-or-undervalued-3681905",
        "imagepath": "",
        "date": "2025-11-08 08:10:40",
        "description": "As of 7 November 2025, the valuation grade for Jyothy Labs has moved from very attractive to attractive, indicating a shift in market perception. Based on the current analysis, the company appears to be fairly valued. Key ratios include a PE ratio of 30.63, an EV to EBITDA of 21.82, and a ROCE of 29.33%. \n\nIn comparison to its peers, Jyothy Labs maintains a competitive position with its PE ratio being significantly lower than that of Hindustan Unilever at 53.63 and Nestle India at 81.21, both of which are categorized as very expensive. Despite a recent decline in stock performance, with a year-to-date return of -21.62% compared to the Sensex's 6.50%, the company's strong fundamentals suggest it is positioned well within the FMCG sector...."
      },
      {
        "title": "Is Jyothy Labs overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-jyothy-labs-overvalued-or-undervalued-3678062",
        "imagepath": "",
        "date": "2025-11-07 08:12:10",
        "description": "As of 6 November 2025, Jyothy Labs has moved from an attractive to a very attractive valuation grade. The company is currently considered undervalued, especially when compared to its peers in the FMCG sector. Key ratios include a PE ratio of 30.81, an EV to EBITDA of 21.96, and a ROCE of 29.33%, which indicate strong operational efficiency and profitability.\n\nIn comparison to its peers, Jyothy Labs stands out with a significantly lower PE ratio than Hindustan Unilever at 54.11 and Nestle India at 81.85, both of which are categorized as very expensive. Additionally, the PEG ratio for Jyothy Labs is 0.00, suggesting that the stock may be undervalued relative to its growth potential, especially when contrasted with Pidilite Industries, which has a PEG of 4.58. Despite recent underperformance against the Sensex, particularly over the past year with a return of -35.94% compared to the Sensex's 3.65%, the valuati..."
      },
      {
        "title": "Jyothy Labs Faces Mixed Technical Signals Amidst Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jyothy-labs-technical-trend-shifts-from-mildly-bearish-to-bearish-amid-stock-decline-3678648",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/JyothyLabs_technicaldot_3678648.png",
        "date": "2025-11-07 08:08:41",
        "description": "Jyothy Labs, a small-cap FMCG company, has experienced a significant decline in stock performance over the past year, down 35.94%. Recent evaluations show mixed technical indicators, with some suggesting bullish trends while others indicate bearish sentiment. Year-to-date, the stock has underperformed compared to the Sensex."
      },
      {
        "title": "How has been the historical performance of Jyothy Labs?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-jyothy-labs-3677269",
        "imagepath": "",
        "date": "2025-11-06 22:59:32",
        "description": "Answer:\nThe historical performance of Jyothy Labs shows a consistent growth trajectory in net sales and profit over the years.\n\nBreakdown:\nJyothy Labs has demonstrated a steady increase in net sales, rising from 1,711.17 Cr in Mar'20 to 2,846.98 Cr in Mar'25. The total operating income followed a similar trend, reaching 2,846.98 Cr in Mar'25, up from 1,711.17 Cr in Mar'20. The company's operating profit (PBDIT) also saw significant growth, climbing to 555.17 Cr in Mar'25 from 271.08 Cr in Mar'20, reflecting an improved operating profit margin of 17.55% in Mar'25 compared to 14.67% in Mar'20. Profit before tax increased to 488.81 Cr in Mar'25, up from 181.50 Cr in Mar'20, while profit after tax reached 370.38 Cr, compared to 162.58 Cr in Mar'20. The total assets of Jyothy Labs grew from 1,733.49 Cr in Mar'20 to 2,663.44 Cr in Mar'25, indicating a robust expansion in the company's financial base. Additionally..."
      }
    ],
    "total": 5567,
    "sid": "973634",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/jyothy-labs-973634"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Feb-2026",
      "details": "Intimation of Earnings Conference Call for the Quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Considering And Approving Un-Audited Financial Results Of The Company For The Quarter Ended December 31 2025.",
      "datetime": "02-Feb-2026",
      "details": "Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Un-audited Financial Results of the Company for the quarter and nine months ended December 31 2025 with limited review thereon by the Statutory Auditors of the Company",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Please find enclosed certificate under Regulation 74(5) of SEBI (DP) Regulations 2018.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jyothy Labs Ltd. has declared <strong>350%</strong> dividend, ex-date: 28 Aug 25",
          "dt": "2025-08-28",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jyothy Labs Ltd. has announced <strong>1:5</strong> stock split, ex-date: 12 Dec 08",
          "dt": "2008-12-12",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Jyothy Labs Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 28 Jun 18",
          "dt": "2018-06-28",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Jyothy Labs falling/rising?

2025-12-04 00:54:22

Recent Price Movement and Market Performance Jyothy Labs closed at ₹291.95, down ₹3.55 or 1.2% as of 08:57 PM on 03-Dec. The stock has been on a consistent decline, losing 5.33% over the past week and underperforming its sector by 0.32% on the day. This marks the fifth consecutive day of losses, with the stock falling 5.33% during this period. Notably, Jyothy Labs is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. Investor participation has seen a slight uptick, with delivery volumes rising by 2.09% to 2.33 lakh shares on 02 Dec compared to the five-day average. The stock remains sufficiently liquid, supporting trade sizes of approximately ₹0.22 crore based on 2% of the fi...

Jyothy Labs Sees Revision in Market Evaluation Amidst Challenging FMCG Landscape

2025-11-27 10:06:45

Jyothy Labs has experienced a revision in its market evaluation, reflecting shifts in key analytical parameters that influence investor perception. The recent changes highlight a complex interplay of factors including quality, valuation, financial trends, and technical outlook within the FMCG sector.

How has been the historical performance of Jyothy Labs?

2025-11-13 00:27:57

Answer: The historical performance of Jyothy Labs shows a consistent growth trajectory in net sales and profitability over the years. Breakdown: Jyothy Labs has demonstrated a steady increase in net sales from INR 1,711.17 crore in March 2020 to INR 2,846.98 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached INR 2,846.98 crore in March 2025, up from INR 1,711.17 crore in March 2020. The company's operating profit (PBDIT) also reflects this positive trend, increasing from INR 271.08 crore in March 2020 to INR 555.17 crore in March 2025. Profit before tax has similarly improved, rising from INR 181.50 crore in March 2020 to INR 488.81 crore in March 2025. The profit after tax has shown a notable increase as well, from INR 162.58 crore in March 2020 to INR 370.38 crore in March 2025. In terms of assets, total assets grew from INR 1,733.49 crore in March 2020 to ...

Is Jyothy Labs overvalued or undervalued?

2025-11-10 08:12:33

As of 7 November 2025, the valuation grade for Jyothy Labs has moved from very attractive to attractive, indicating a shift in perception regarding its market valuation. The company is currently assessed as fairly valued. Key ratios include a PE ratio of 30.63, an EV to EBITDA of 21.82, and a ROCE of 29.33%. When compared to its peers, Jyothy Labs' PE ratio is significantly lower than that of Hindustan Unilever at 53.63 and Nestle India at 81.21, both categorized as very expensive. Despite the attractive valuation, Jyothy Labs has underperformed in the market, with a year-to-date return of -21.62% compared to a 6.50% gain in the Sensex. This performance reinforces the notion that while the company is fairly valued, it may face challenges in the near term....

Is Jyothy Labs overvalued or undervalued?

2025-11-09 08:10:52

As of 7 November 2025, the valuation grade for Jyothy Labs has moved from very attractive to attractive. The company is currently considered fairly valued. Key ratios include a PE ratio of 30.63, an EV to EBITDA ratio of 21.82, and a ROCE of 29.33%. In comparison to its peers, Jyothy Labs has a significantly lower valuation than Hindustan Unilever, which has a PE ratio of 53.63, and Nestle India, with a PE ratio of 81.21. Despite its recent stock performance underperforming the Sensex, with a YTD return of -21.62% compared to the Sensex's 6.50%, the company's solid ROCE and attractive valuation relative to its peers suggest it remains a viable investment option....

Is Jyothy Labs overvalued or undervalued?

2025-11-08 08:10:40

As of 7 November 2025, the valuation grade for Jyothy Labs has moved from very attractive to attractive, indicating a shift in market perception. Based on the current analysis, the company appears to be fairly valued. Key ratios include a PE ratio of 30.63, an EV to EBITDA of 21.82, and a ROCE of 29.33%. In comparison to its peers, Jyothy Labs maintains a competitive position with its PE ratio being significantly lower than that of Hindustan Unilever at 53.63 and Nestle India at 81.21, both of which are categorized as very expensive. Despite a recent decline in stock performance, with a year-to-date return of -21.62% compared to the Sensex's 6.50%, the company's strong fundamentals suggest it is positioned well within the FMCG sector....

Is Jyothy Labs overvalued or undervalued?

2025-11-07 08:12:10

As of 6 November 2025, Jyothy Labs has moved from an attractive to a very attractive valuation grade. The company is currently considered undervalued, especially when compared to its peers in the FMCG sector. Key ratios include a PE ratio of 30.81, an EV to EBITDA of 21.96, and a ROCE of 29.33%, which indicate strong operational efficiency and profitability. In comparison to its peers, Jyothy Labs stands out with a significantly lower PE ratio than Hindustan Unilever at 54.11 and Nestle India at 81.85, both of which are categorized as very expensive. Additionally, the PEG ratio for Jyothy Labs is 0.00, suggesting that the stock may be undervalued relative to its growth potential, especially when contrasted with Pidilite Industries, which has a PEG of 4.58. Despite recent underperformance against the Sensex, particularly over the past year with a return of -35.94% compared to the Sensex's 3.65%, the valuati...

Jyothy Labs Faces Mixed Technical Signals Amidst Market Challenges

2025-11-07 08:08:41

Jyothy Labs, a small-cap FMCG company, has experienced a significant decline in stock performance over the past year, down 35.94%. Recent evaluations show mixed technical indicators, with some suggesting bullish trends while others indicate bearish sentiment. Year-to-date, the stock has underperformed compared to the Sensex.

How has been the historical performance of Jyothy Labs?

2025-11-06 22:59:32

Answer: The historical performance of Jyothy Labs shows a consistent growth trajectory in net sales and profit over the years. Breakdown: Jyothy Labs has demonstrated a steady increase in net sales, rising from 1,711.17 Cr in Mar'20 to 2,846.98 Cr in Mar'25. The total operating income followed a similar trend, reaching 2,846.98 Cr in Mar'25, up from 1,711.17 Cr in Mar'20. The company's operating profit (PBDIT) also saw significant growth, climbing to 555.17 Cr in Mar'25 from 271.08 Cr in Mar'20, reflecting an improved operating profit margin of 17.55% in Mar'25 compared to 14.67% in Mar'20. Profit before tax increased to 488.81 Cr in Mar'25, up from 181.50 Cr in Mar'20, while profit after tax reached 370.38 Cr, compared to 162.58 Cr in Mar'20. The total assets of Jyothy Labs grew from 1,733.49 Cr in Mar'20 to 2,663.44 Cr in Mar'25, indicating a robust expansion in the company's financial base. Additionally...

View All News